-+ 0.00%
-+ 0.00%
-+ 0.00%

UPSTREAM BIO INC - OVER 90% OF PATIENTS TRANSITIONED TO PHASE 2 VALOUR STUDY

Reuters·02/11/2026 11:00:01

Please log in to view news